Technologies

Life Sciences & Biotechnology, COVID-19 Technology

Title:

Low-cost rapid diagnostic kit

Area:

Life Sciences & Biotechnology, COVID-19 Technology

Focus Area:

Diagnostics kit development for COVID-19

Technology Readiness Index:

preliminary testing has been done and it is to be validated by ICMR/NIV.

Brief Description

Description :

The kit will be able to detect two types of antibodies – Immunoglobulin M (IgM) and Immunoglobulin G (IgG). IgM is the first antibody that appears in human body when it is exposed to a virus or any other antigen. Presence of IgG antibody in the body, in contrast, is indicative of an individual's immune status to particular pathogens.

Related Technologies